← Back to Clinical Trials
Recruiting NCT04721717

NCT04721717 AIM's Writing for Healing: A Workshop for Individuals Living With Paralysis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04721717
Status Recruiting
Phase
Sponsor University of Alabama at Birmingham
Condition Spinal Cord Injuries
Study Type OBSERVATIONAL
Enrollment 160 participants
Start Date 2020-09-01
Primary Completion 2027-03-28

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 160 participants in total. It began in 2020-09-01 with a primary completion date of 2027-03-28.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The UAB Institute for Arts In Medicine (AIM) is currently implementing an expressive emotional writing pilot project for adults with paralysis caused by neurological conditions such as traumatic head or spinal cord injury.

Eligibility Criteria

Inclusion Criteria: 1. Age 18 or older with paralysis living in the community 2. limb paralysis resulting from a traumatic event/accident or neurological disease (e.g., spinal cord injury, head injury, stroke, multiple sclerosis, Transverse myelitis, poliomyelitis, peripheral neuropathy, Parkinson's disease, ALS, botulism, and Guillain-Barré syndrome etc) happened after childhood 3. a non-traumatic spinal cord injury may be caused by arthritis, cancer, inflammation, infections or disk degeneration of the spine 4. caregivers of people with amyotrophic lateral sclerosis 5. able to communicate verbally or through writing Exclusion Criteria: 1. known maladaptive behavioral patterns, exhibition of overt psychotic symptoms (e.g., presence of hallucinations, delusions, or thought disorders) 2. congenital (e.g., spinal bifida, cerebral palsy)

Frequently Asked Questions

Who can join the NCT04721717 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Spinal Cord Injuries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04721717 currently recruiting?

Yes, NCT04721717 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Alabama at Birmingham to inquire about joining.

Where is the NCT04721717 trial being conducted?

This trial is being conducted at Birmingham, United States.

Who is sponsoring the NCT04721717 clinical trial?

NCT04721717 is sponsored by University of Alabama at Birmingham. The trial plans to enroll 160 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology